Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

What's been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper explains how monogenic and polygenic factors converge on key growth ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge.

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...

A major new study has revealed that the genes we inherit at birth play a much larger role in cancer than previously ...

How are advanced diagnostics benefitting patients? Our recent webinar discussed next-gen molecular analysis in precision ...

GeneDx Holdings Corp. WGS is slated to report its first-quarter 2025 results on April 30, before the market opens. The ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet ...

Overview of Cancer DiagnosticsThe Global Cancer Diagnostics Market is valued at USD 19.5 Billion in 2023 and is projected to reach a value of USD 54.6 Billion by 2032 at a CAGR (Compound Annual Growth ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $142.0, a high ...